ArticleDiagnostic pathology2015

miR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF-β-mediated EMT.

Qian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.